Regenerative Research

Foot & Ankle Regenerative Research: The Evidence & Clinical Science

Transparent, Peer-Reviewed Evidence for Non-Surgical Restorative Therapies

Regenerative medicine is one of the most rapidly evolving fields in foot and ankle care; Navigating the claims surrounding non-surgical therapies can be challenging for patients. This clinical research content is designed to provide clear, peer-reviewed evidence regarding what modern literature shows—and where research continues to evolve—so you can make an informed decision about your care.

The 10R™ Framework: Foundation vs. Regenerative Adjuncts

Our proprietary 10R™ Treatment Philosophy organizes lower-extremity care into a structured, evidence-guided continuum.

We operate under the foundational medical principle of primum non nocere—first, do no harm. We always start with the simplest, least invasive options backed by proven track records.

Reducing Pain and Swelling and Active Rehabilitation Is the Foundation

In non-surgical musculoskeletal care, active rehabilitation—including progressive loading, targeted stretching, strengthening, and mechanical offloading (custom orthotics and footwear modifications)—remains the most proven foundation.

Advanced energy-based devices and biological injections are optional adjuncts, designed to support your body’s recovery alongside active rehabilitation, not replace it.

A Closer Look at Regenerate (Recharge, Reset, Recruit)

Within of our 10R™ framework, the Regenerate step focuses on non-invasive energy modalities and injectable biological therapies. These options are categorized by their primary intended mechanism:

Recharge — Cellular Energy Support (High-Energy Laser / PBM)

How It Works: Photobiomodulation (PBM) uses targeted wavelengths of light to interact with chromophores in mitochondrial membranes (such as cytochrome c oxidase).
Intended Purpose: Research indicates PBM is thought to support cellular ATP production, temporary local micro-vascular circulation, and modulation of inflammatory signaling cascades in acute or subacute tissue strain.

Reset — Electromagnetic Signaling (Magnetotransduction / EMTT)

How It Works: Extracorporeal Magnetotransduction Therapy (EMTT) delivers high-energy magnetic pulses (up to 80–150 mT) at high oscillation frequencies.
Intended Purpose: Laboratory and clinical models suggest high-intensity magnetic fields may influence cell membrane ion exchange (such as intracellular calcium influx) and upregulate key gene markers associated with tissue matrix mineralization and vascular signaling.

Recruit — Biological Signaling & Recruitment (ESWT & Injection Therapies)

How It Works: Extracorporeal Shockwave Therapy (ESWT) delivers acoustic pressure pulses directly to damaged fascia or tendons.

This can include advanced biologic allografts or using cells from your own body — like Platelet-Rich Plasma (PRP), Bone Marrow Concentrate (BMAC), or Adipose (ADSC) — directly to the injury to supply concentrated cellular tissue healing and growth factors.
Intended Purpose: Acoustic shockwaves are designed to create micro-disruptions in chronic, stagnant tissue, which clinical research indicates can recruit local micro-vascularization (VEGF expression) and stimulate local cellular repair signaling. Injection therapies deliver allograft or autogenous growth factors intended to support structural collagen remodeling in selected non-resolving injuries.

How We Evaluate Scientific Evidence

To maintain complete clinical transparency, every modality in our practice is mapped against peer-reviewed research and evidence:

Level 1 (Strong Evidence): Supported by randomized controlled trials or systematic reviews.

Level 2–3 (Moderate / Emerging Evidence): Supported by clinical cohort studies.

Level 4–5 (Investigational / Laboratory): Supported by cell culture or preclinical laboratory models.

Shared Decision-Making (SDM): The A–B–C Framework

Shared Decision-Making ensures your treatment plan is built collaboratively—combining clinical evidence with your personal goals and values. We group treatment options into three clear categories:

SDM A — “We Should Definitely Do This” (Essential Foundation)
- What it means: Proven first-line care supported by high-certainty research (Level 1 evidence).
SDM B — “We Should Probably Do This” (Recommended Adjuncts)
- What it means: Strong supporting research showing clear clinical benefit when added to foundational care.
SDM C — “We Could Consider This” (Optional / Emerging Options)
- What it means: Emerging or investigational options backed by laboratory or preliminary clinical data.